195 related articles for article (PubMed ID: 25048051)
1. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma.
Alaeddini M; Etemad-Moghadam S
J Oral Pathol Med; 2015 Mar; 44(3):234-8. PubMed ID: 25048051
[TBL] [Abstract][Full Text] [Related]
2. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of S100 protein in malignant melanomas of the facial skin and oral cavity.
Korabiowska M; Mirecka J; Brinck U; Szuta M; Stypulkowska J; Wiese G; Bartkowski S; Schauer A
J Nihon Univ Sch Dent; 1994 Jun; 36(2):117-21. PubMed ID: 7521913
[TBL] [Abstract][Full Text] [Related]
4. Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosa.
Tanaka N; Odajima T; Mimura M; Ogi K; Dehari H; Kimijima Y; Kohama G
Oral Oncol; 2001 Apr; 37(3):308-14. PubMed ID: 11287287
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of S-100 protein and its subunits in melanotic lesions in the oral mucosa and skin.
Fujita S; Takahashi H; Tsuda N; Okabe H
J Oral Pathol Med; 1991 Oct; 20(9):429-32. PubMed ID: 1804988
[TBL] [Abstract][Full Text] [Related]
6. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic differences between uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
[TBL] [Abstract][Full Text] [Related]
8. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
[TBL] [Abstract][Full Text] [Related]
9. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
[TBL] [Abstract][Full Text] [Related]
10. Oral cavity neuroendocrine carcinoma: a comparison study with cutaneous Merkel cell carcinoma and other mucosal head and neck neuroendocrine carcinomas.
Lewis JS; Duncavage E; Klonowski PW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):209-17. PubMed ID: 20659699
[TBL] [Abstract][Full Text] [Related]
11. Adhesion molecules in primary oral mucosal melanoma: study of claudins, integrins and immunoglobulins in a series of 35 cases.
Bologna SB; Nico MM; Hsieh R; Coutinho-Camillo CM; Buim ME; Fernandes JD; Sangueza M; Soares FA; Lourenço SV
Am J Dermatopathol; 2013 Jul; 35(5):541-54. PubMed ID: 23715077
[TBL] [Abstract][Full Text] [Related]
12. MITF positivity in atypical fibroxanthoma: a diagnostic pitfall.
Tallon B; Beer TW
Am J Dermatopathol; 2014 Nov; 36(11):888-91. PubMed ID: 25238448
[TBL] [Abstract][Full Text] [Related]
13. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
[TBL] [Abstract][Full Text] [Related]
14. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
16. p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin.
Vogt T; Zipperer KH; Vogt A; Hölzel D; Landthaler M; Stolz W
Histopathology; 1997 Jan; 30(1):57-63. PubMed ID: 9023558
[TBL] [Abstract][Full Text] [Related]
17. Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance.
Chen N; Gong J; Chen X; Meng W; Huang Y; Zhao F; Wang L; Zhou Q
Hum Pathol; 2009 Jul; 40(7):950-6. PubMed ID: 19269012
[TBL] [Abstract][Full Text] [Related]
18. Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Kellner S; Marx D; Schauer A
Anticancer Res; 1995; 15(3):885-9. PubMed ID: 7645976
[TBL] [Abstract][Full Text] [Related]
19. CD-44: a marker of metastases of head and neck melanomas.
Korabiowska M; Brinck U; Hönig J; Mora O; Bartkowski S; Schauer A
In Vivo; 1995; 9(3):253-6. PubMed ID: 8562892
[TBL] [Abstract][Full Text] [Related]
20. Expression of mitochondrial dynamics markers during melanoma progression: Comparative study of head and neck cutaneous and mucosal melanomas.
Soares CD; de Lima Morais TM; Mariano FV; Altemani A; Corrêa MB; Reis RRDD; Amorim LS; Ferreira SMS; de Almeida OP; Carlos R; Jorge J
J Oral Pathol Med; 2019 May; 48(5):373-381. PubMed ID: 30916813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
